Related Experiment Video

Updated: Jun 7, 2026

Isolation of Atrial Myocytes from Adult Mice
08:34

Isolation of Atrial Myocytes from Adult Mice

Published on: July 25, 2019

N-terminal pro-B-type natriuretic peptide is associated with sudden cardiac death risk: the Cardiovascular Health

Kristen K Patton1, Nona Sotoodehnia, Christopher DeFilippi

  • 1Division of Cardiology, University of Washington, Seattle, Washington 98115, USA.

Heart Rhythm
|November 4, 2010
PubMed

Insights

Elevated N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels are a significant predictor of sudden cardiac death (SCD) risk in older adults. This finding aids in identifying individuals who may benefit from targeted interventions.

Area of Science:

  • Cardiology
  • Biomarker Research
  • Public Health

Background:

  • Sudden cardiac death (SCD) causes 250,000-450,000 annual deaths, often without prior diagnosis.
  • Elevated B-type natriuretic peptide levels are linked to heart failure, mortality, and sudden death in women.

Purpose of the Study:

  • To investigate the association between N-terminal pro-B-type natriuretic peptide (NT-proBNP) and SCD risk.
  • Analysis conducted within the Cardiovascular Health Study population.

Main Methods:

  • Examined SCD risk in 5,447 participants based on baseline NT-proBNP levels.
  • Utilized covariate-adjusted Cox regression models to estimate hazard ratios for SCD.

Main Results:

  • Higher NT-proBNP levels strongly correlated with increased SCD risk.
  • Unadjusted hazard ratio for the highest NT-proBNP quintile was 4.2 (95% CI [2.9, 6.1]).
  • Association persisted after adjusting for clinical characteristics and risk factors (adjusted HR 2.5; 95% CI [1.6, 3.8]).

Conclusions:

  • NT-proBNP is a valuable predictor of SCD risk in community-dwelling older adults, beyond traditional factors.
  • This biomarker may help identify at-risk individuals for proactive management of underlying conditions.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...